Ask the doctor : the SSRI Controversy
By: Levitas, Andrew S.
Contributor(s): Hurley, Anne DesNoyers.
Series: Mental Health Aspects of Developmental Disabilities 8 (2) 2005: 61-67.Publisher: 2005Content type: text Media type: unmediated Carrier type: volume Subject(s): CHILDREN | INTELLECTUAL DISABILITY | DEVELOPMENTAL DISABILITIES | DEPRESSION | TREATMENT | DIAGNOSIS | PSYCHIATRIC DISORDERS | AUTISM | PSYCHOTROPIC DRUGS | POLITICS | AUTISM | SUICIDE | ADOLESCENTSSummary: Explains that the SSRI (specific serotonin reuptake inhibitors - used to treat some psychiatric disorders, particularly depression) controversy has arisen in the last two years, where government alerts in the UK, Canada and the US warned against the use of these for children and adolescents due to increased reports, in some studies, of suicide. Backgrounds the issues, discusses the politics involved and offers cautions in particular about undiagnosed depression in patients with autism spectrum disorders.Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|
Article Research | IHC Library | Article (Browse shelf(Opens below)) | Available (Article available on request) | 22152 |
Explains that the SSRI (specific serotonin reuptake inhibitors - used to treat some psychiatric disorders, particularly depression) controversy has arisen in the last two years, where government alerts in the UK, Canada and the US warned against the use of these for children and adolescents due to increased reports, in some studies, of suicide. Backgrounds the issues, discusses the politics involved and offers cautions in particular about undiagnosed depression in patients with autism spectrum disorders.
There are no comments on this title.